Relationship between diabetes and periodontal infection

Abstract

Periodontal disease is a high prevalent disease. In the United States 47.2% of adults ≥ 30 years old have been diagnosed with some type of periodontitis. Longitudinal studies have demonstrated a two-way relationship between diabetes and periodontitis, with more severe periodontal tissue destruction in diabetic patients and poorer glycemic control in diabetic subjects with periodontal disease. Periodontal treatment can be successful in diabetic patients. Short term effects of periodontal treatment are similar in diabetic patients and healthy population but, more recurrence of periodontal disease can be expected in no well controlled diabetic individuals. However, effects of periodontitis and its treatment on diabetes metabolic control are not clearly defined and results of the studies remain controversial.

Key Words: Diabetes, Diabetes mellitus, Periodontitis, Periodontal disease, Periodontal treatment, Scaling and root planning, Non surgical periodontal treatment, Antibiotic, Glycosylated hemoglobin, C-reactive protein

Core tip: Longitudinal studies have demonstrated a two-way relationship between diabetes and periodontitis, with more severe periodontal tissue destruction in diabetic patients and poorer glycemic control in diabetic subjects with periodontal disease. Periodontal treatment can be successful in diabetic patients, but more recurrence of periodontal disease can be expected in non well controlled diabetic individuals. However, effects of periodontitis and its treatment on diabetes metabolic control are not clearly defined and results of the studies remain controversial. Recommendations for future investigations are included in this review.

PERIODONTAL DISEASE

What is periodontal disease?

Periodontal disease is the destruction of the tissues that support the tooth by accumulation and maturation of oral bacteria on teeth.

Periodontal diseases include two major entities, gingivitis and periodontitis. Gingivitis is characterized by reversible inflammation of periodontal tissues whereas periodontitis also presents destruction of tooth supporting structures, and may lead to tooth loss. Exiting evidence indicates that gingival inflammation (gingivitis) is required for periodontitis, however some gingivitis never transform to periodontitis[1,2]. This is because bacterial plaque accumulation is necessary for the onset of both entities but individual susceptibility is required to develop periodontitis[2,3].

The currently used classification of periodontal diseases was introduced by the 1999 International Workshop for a Classification of Periodontal Diseases and Conditions[4]. Since the current classification has been used only in the last years, a substantial part of the existing literature on the prevalence and extent of periodontal diseases in various populations is still based on earlier classification systems.

Due to its high prevalence in current populations, it has become a public health priority. Epidemiologic studies have determined that about 50% of the population suffer from gingivitis and approximately 14% show periodontitis[5]. This percentage was higher in a recent study on United States population, which showed that 47.2% of adults ≥ 30 years old had periodontitis. Prevalence of periodontitis increased with age up to the point that 70.1% of adults ≥ 65 years old were affected by periodontal disease[6]. Men exhibit worse periodontal status than women [(56.4% vs 38.4%), as well as those with limited education (66.9%) and income (65.4%)]. These factors, together with cigarette smoking are increased risk factors for periodontal progression[7].

Etiology and pathogenesis of periodontal disease

Microorganisms in combination with individual host susceptibility and environmental factors are the main etiologic factors of periodontal diseases.

Plaque accumulation on teeth produces gingivitis, but the degree of inflammation and destruction of the alveolar bone that supports teeth depend on the host susceptibility[8].

Oral bacteria can damage periodontal tissues through the action of matrix-degrading enzymes and molecules that affect host cells. The transition from gingivitis to periodontitis involves the spreading of the inflammatory front to deeper areas in the connective tissue. However the reason why this happens is not well established. One etiopathogenic mechanism could involve the presence of bacteria or their products, such as lipopolysaccharides, in the periodontal connective tissue. They may induce an immune response with production of interleukins and tumor necrosis factor (TNF), which play an important role in the regulation of inflammatory processes. This inflammation stimulates the production of secondary mediators, which amplify the inflammatory response. Simultaneously, the presence of these cytokines reduces the ability to repair damaged tissue by cells such as fibroblasts, and finally, bacterial products and this inflammatory cascade stimulate osteoclastogenesis, leading to alveolar bone destruction[9,10] (Figure 1).

Figure 1 Etiology and pathogenesis of periodontal diseases. Adapted from: Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997; 14: 9-11.

Several studies have shown how gingival inflammation can be modulated by a number of conditions. Systemic diseases, steroid hormones variations, nutritional deficiency, the intake of drugs, diabetes, tobacco smoking and other conditions have comprehensive and profound effects on the host, resulting in an increased response to bacterial plaque accumulation[10].

The high prevalence of Helicobacter pylori (H. pylori) among the microorganisms isolated from the oral environment induce to think that it may have an effect in the development of periodontal disease. Umeda et al[11] determined that periodontal patients showed a higher level of H. pylori than healthy subjects but, there was no significant correlation between the presence of H. pylori and the severity of periodontitis[12]. The addition of periodontal treatment to eradication therapy may reduce H. pylori recurrence compared with eradication therapy alone in periodontal patients suffering from gastric diseases associated with H. pylori[13].

Clinical manifestation of periodontal disease

Clinical signs of gingival inflammation (gingivitis) involve enlarged gingival contours due to edema or fibrosis, color transition to a red and/or bluish red hue, elevated sulcular temperature, bleeding upon probing and, increased gingival exudates (Figure 2).

Figure 2 Clinical features of plaque-induced gingivitis associated with systemic diseases (diabetes mellitus-associates gingivitis).

Periodontitis clinical features include clinical attachment loss (CAL), alveolar bone loss (BL), periodontal pocketing and gingival inflammation. In addition, enlargement or recession of the gingiva; increase tooth mobility, drifting, and even tooth exfoliation may occur (Figure 3)[14].

Figure 3 Clinical features of chronic periodontitis in diabetic subject.

Diagnosis of periodontal disease

Clinical evaluation includes periodontal probing (Figure 4) to evaluate: (1) Probing depth: the distance a periodontal probe penetrates into a periodontal pocket measured from the gingival margin to its bottom; (2) Clinical attachment level: The distance from the cemento-enamel junction to the bottom of the periodontal pocket; (3) Bleeding on probing. Bleeding after probing to the base of the periodontal pocket has been a common way to identify presence of subgingival inflammation; and (4) Tooth mobility and furcations. The movement of a tooth in its socket resulting from an applied force can be classified into three categories. Furcation involvement is defined as BL affecting the base of the root trunk of a tooth where two or more roots meet.

Figure 4 Clinical diagnosis of periodontitis.

Radiographic evaluation will show if alveolar bone that support tooth roots is lost. In a healthy situation alveolar bone will remain 1-2 mm below the crown of the teeth. If bone is located further from the crown, it means that loss has occurred (Figure 5).

Figure 5 Radiographic diagnosis of periodontitis.

Classification of periodontal disease

In 1999, the American Academy of Periodontology organized an international symposium with the aim of reaching a consensus regarding the classification of periodontal diseases and disorders, resulting in eight categories: gingival diseases, chronic periodontitis, aggressive periodontitis, periodontitis as manifestation of systemic diseases, necrotizing periodontal diseases, periodontal abscesses, periodontitis associated with endodontic lesions and, developmental or acquired deformities and conditions[4,15,16].

It is possible to include in this classification additional subcategories such as “diabetes mellitus-associated chronic periodontitis” and “diabetes mellitus-associated aggressive periodontitis” under the category of periodontitis as manifestation of systemic diseases.

INTERRELATIONSHIP BETWEEN PERIODONTITIS AND DIABETES

Investigations have demonstrated associations between periodontitis and various systemic diseases[17,18] such as cardiovascular disorders[19,20], respiratory diseases[21,22], osteoporosis[23,24], immunodeficiencies[25] and also diabetes mellitus[26].

As already mentioned, longitudinal studies have demonstrated a two-way relationship between diabetes and periodontitis, with more severe periodontal tissue destruction in diabetic patients and poorer glycemic control in diabetic subjects with periodontal disease[27-30].

Effect of diabetes on periodontal disease and periodontal treatment

Diabetes has been associated to different oral diseases such as salivary and taste dysfunction, oral bacterial and fungal infections (i.e., candidiasis), and oral mucosa lesions (i.e., stomatitis, geographic tongue, traumatic ulcer, lichen planus,…)[31,32]. Diminished salivary flow and burning mouth are other oral characteristics in diabetic patients with poor glycemic control. Also, different oral pathologies such as, lichen planus, leukoplakia and lichenoid reactions are associated to diabetic subjects due to immunosuppression and/or drugs used. In addition, delayed mucosal wound healing, mucosal neuro-sensory disorders, decay lesions and tooth loss have been reported in diabetic patients[33]. Xerostomia is a frequent symptom found in diabetic patients on oral hypoglycemic agents, and it may facilitate the onset of some fungal opportunistic infection. Candidiasis has been reported in patients with poorly controlled diabetes (Figure 6).

Figure 6 Clinical features of acute pseudomembranous candidiasis.

Evidence suggests that diabetes leads to worsening of periodontal disease, and a significant association between diabetes and periodontitis has been demonstrated. Periodontal disease has a higher incidence in diabetic patients, and it is more prevalent and severe if compared with a healthy population[27,34]. Lalla et al[35] determined the prevalence of periodontitis in different age cohorts. It was 4.8 times higher among diabetic patients compared to non diabetics when the 15 to 24-year age cohort was considered, and 2.3 higher in the 25-34 year group. Also, CAL was higher in diabetic patients when the 15 to 55-year age cohort was considered. Lim et al[36] estimated that the glycemic control was the most important risk factor related to severity and extent of periodontitis. Other authors like Lalla et al[37] established that the rate of periodontal destruction is related to inappropriate glycemic control in diabetic patients so that accurate metabolic control could be important to prevent periodontal complications. Thus, glycemic control and the diabetes onset are critical factors in periodontal disease progression but it should be considered that substantial heterogeneity exists within diabetics[38].

Glycosylated hemoglobin (HbA1c) allows the control of serum glucose levels in an interval of 120 d and is a useful decision-making tool. Diabetes micro- and macrovascular complications are related to increased levels of HbA1c. The risk of periodontitis is 3-fold times higher among diabetic patients[39], being its prevalence and severity even greater in diabetic patients presenting elevated HbA1c levels[40].

Different hypotheses have been proposed to explain the influence of diabetes mellitus on periodontitis but they are all currently under investigation and remain somewhat controversial. Two similar but distinct pathogenic pathways may justify the biologic plausibility, a possible common origin of the two diseases which results in a host susceptible to either diseases[41], or a direct causal relationship in which, through the effects of advanced glycosylation end products (AGEs), diabetes triggers an increased inflammatory phenotype in cells[5,27]. Studies have shown how chronic hyperglycemia produces AGEs that can bind to specific receptors (RAGE) on different cells such as fibroblast, endothelial cells and macrophages[42]. Thereby, macrophages are transformed into hypereactive cells that produce pro-inflammatory cytokines such as interleukins 1β and 6 (IL-1β, IL-6) and TNF-α. AGEs can also alter endothelial cells which will become hyperpermeable and hyperexpressive for adhesion molecules, while fibroblasts will show decreased collagen production[43]. Therefore, AGEs produced by chronic hyperglycemia can produce hyper inflammatory responses, vascular modifications, altered healing and increased predisposition to infections (Figure 7). Lalla et al[44] supported the hypothesis that the activation of RAGE contributes to pathogenesis of periodontitis in diabetic patients. Increased accumulation of AGEs and their interaction with RAGE in diabetic gingiva leads to hyper production of proinflammatory cytokines, vascular dysfunction, and loss of effective tissue integrity and barrier function.

Figure 7 How diabetes mellitus could contribute to the development of periodontal disease (Llambés F, Caffesse R, Arias S). TNF: Tumor necrosis factor; IL-1β: Interleukins 1β; AGE: Advanced glycosylation end product; RAGE: Receptors AGE.

Despite these facts, periodontal treatment can be successful in diabetic patients. Short term effects of periodontal treatment are similar in diabetic patients and healthy population[45-47] but, more recurrence of periodontal disease can be expected in non well controlled diabetic individuals[26].

Effect of periodontal disease and its treatment on diabetes

The National Health and Nutrition Examination Survey 2009-2010 reported that prevalence of diabetes was 12.5% among periodontal patients, but only 6.3% in subjects without periodontitis[48].

If diabetic individuals are at a higher risk for periodontitis, it is also important to determine what effects periodontitis and its treatment may have on diabetes. It would be reasonable to think that periodontal inflammation, as any other infections, can have an adverse effect on diabetes glycemic control, compromising diabetes management in these individuals. Most evidence on this issue is derived from interventional and observational studies, indicating that periodontitis affects the glycemic control of diabetic patients. HbA1c values < 7% are related with proper glycemic levels whilst > 8% values represents poorly controlled glycemia.

Longitudinal studies have demonstrated that severe periodontitis is associated with poorly controlled glycemia, higher HbA1c levels and development of diabetic systemic complications[1,30,49]. It also has been reported that periodontitis is associated with a slight elevation of HbA1c in non-diabetic subjects (periodontitis may potentially increase the incidence of diabetes), although a clear-cut association could not be established[50].

Studies assumed that periodontal infection may impair glycemic control by increasing insulin tissue resistance[26]. Hence, glycemic level could be improved by non-surgical periodontal treatment removing bacterial plaque accumulation and decreasing gingival inflammation. This assumption is based on studies that observed an improvement in diabetes glycemic control following periodontal therapy[46,51]. It should be considered that other studies did not find such causal relationship, maybe due to inadequate time for periodontal tissues healing, or because periodontitis had not been properly resolved[30,52]. Another reason may be the influence of factors such as diet, physical exercise or use of antidiabetics that can alter significantly HbA1c, and make more difficult to observe the metabolic effect of periodontal treatment[45].

Effect of non-surgical periodontal therapy on diabetes glycemic control

Several studies have investigated the effect of non-surgical periodontal therapy on the glycemic control of diabetic patients. Both non-diabetic and diabetic patients show similar short-term outcomes after non-surgical periodontal therapy in terms of probing depth reductions, gain in CAL and changes in subgingival microbiota[53]. If glycemic control is considered as treatment outcome after non-surgical periodontal therapy, results vary (Table 1).

Table 1 How periodontal therapy affects diabetes glycemic control.

	Ref.	Design	Sample	Follow-up	Outcome	Results
Type 1	Aldridge et al[55]	Randomized clinical trial	23 subjects	2 mo	HbA1c	No changes
	Smith et al[47]	Controlled clinical trial	18 subjects	2 mo	HbA1c	No changes
	Christgau et al[53]	Cohort study	7 subjects	4 mo	HbA1c	No changes
	Llambés et al[45]	Randomized clinical trial	30 subjects	3 mo	HbA1c	0.06% reduction (no changes)
Type 2	Stewart et al[75]	Controlled clinical trial	72 subjects	10 mo	HbA1c	6% reduction
	Kiran et al[51]	Randomized clinical trial	44 subjects	3 mo	HbA1c	0.8% reduction
	Faria-Almeida et al[46]	Cohort study	20 subjects	6 mo	HbA1c	5.7% reduction
	Dağ et al[56]	Controlled clinical trial	45 subjects	3 mo	HbA1c	No changes
	Auyeung et al[57]	Cohort study	75 subjects	12 mo	HbA1c	No changes
	Engebretson et al[58]	Randomized clinical trial	257 subjects	6 mo	HbA1c	No changes
	Gay et al[59]	Randomized clinical trial	126 subjects	4 mo	HbA1c	No changes

Different studies on patients with type 1 diabetes mellitus have not found an additional beneficial effect of periodontal treatment in glycemic control. Llambés et al[45] obtained changes in mean HbA1c of about 0.07%, without statistical significant difference after non-surgical periodontal treatment in type 1 diabetic patients after 3-mo. Similarly, Seppälä et al[54] reported that in poorly-controlled type 1 diabetic patients, non-surgical periodontal therapy had no effect on HbA1c. The same results were observed in the study performed by Aldridge et al[55] who stated no changes in HbA1c levels after non-surgical periodontal therapy in 22 type 1 diabetics with severe periodontitis.

On the other hand, Faria-Almeida et al[46] reported that non-surgical periodontal therapy significantly reduce HbA1c levels about 5.7% in type 2 diabetics, while Dağ et al[56] and Auyeung et al[57] reported that this therapy alone significantly reduced HbA1c levels only in well-controlled diabetics. Smith et al[47] reported that mechanical periodontal therapy alone did not produce a significant change in glycemic control in diabetic patients.

Recently, Engebretson et al[58] indicated that non-surgical periodontal therapy in type 2 diabetics with chronic periodontitis did not improve diabetes glycemic control. According to these findings the use of nonsurgical periodontal treatment in order to reduce levels of HbA1c would not be justified. Lately, Gay et al[59] in a randomized clinical trial where 152 type 2 diabetic patients with periodontitis were treated, determined that no statistically significant differences were found in the changes of HbA1c levels.

Furthermore, current systematic reviews report glycemic control improvement, with a HbA1c reduction of approximately 0.4%, after non-surgical periodontal treatment[60]. A mean reduction of -0.36% of glycosylated HbA1c in subjects with type 2 diabetes has been determined recently[61]. However, the clinical significance of this effect is still unknown. It has been reported that each 1% reduction of HbA1c may be associated with 35% reduction in the risk of microvascular complications[62]. To the best of our knowledge, no studies have evaluated changes in HbA1c levels in non-diabetic patients after non-surgical periodontal therapy.

Effect of non-surgical periodontal therapy in combination with antimicrobials on diabetes glycemic control

Two studies have examined the added benefit of chlorhexidine as adjunct to non-surgical periodontal therapy in diabetic patients. Christgau et al[53] demonstrated that non-surgical periodontal therapy in combination with subgingival irrigation with 0.2% chlorhexidine did not improve HbA1c levels. The same results were achieved when 0.12% chlorhexidine was considered[63].

Iwamoto et al[64] demonstrated a 0.8% reduction in HbA1c in type 2 diabetics after non-surgical periodontal therapy and subgingival use of minocycline gel.

Studies in which systemic antibiotics were used along with mechanical therapy showed a significant improvement in glycemic control in diabetic patients. This may be due to the additional benefits of systemic antibiotics, such as their antimicrobial and host modulation effects, as well as their inhibition of non-enzymatic glycosylation[63,65-67].

Non-surgical periodontal therapy combined with 100 mg doxycycline is associated with a mean HbA1c reduction of 0.6% in type 2 diabetics patients[65]. There is not enough evidence about the use of tetracyclines but it seems to play a role in limiting tissue destruction. Lately, a modest improvement in glycemic control was detected after nonsurgical therapy plus azithromycin[68]. However, Llambés et al[45] show that non-surgical periodontal treatment combined with systemic doxycycline has no effect on HbA1c of type 1 diabetic patients[43].

Effect of surgical periodontal therapy on diabetes glycemic control

Scarce available evidence makes it impossible to determine the response after periodontal surgical treatment in diabetic patients. Diabetic subjects usually show improved periodontitis after surgical periodontal treatment. However, if poor diabetic control is present, more recurrence of periodontal pockets and unfavorable long term response is expected after surgical treatment[53,69]. Effects of surgical periodontal treatment on HbA1c are currently unknown.

The exact mechanism linking periodontitis/periodontal inflammation and HbA1c levels is still not clearly known. In periodontitis, there is an increased production of pro-inflammatory mediators, such as TNF-α, IL-6, IL-1β and interferon gamma (IF-α), and increased levels of acute-phase proteins, such as C-reactive protein (CRP). All these mediators have important effects on glucose and lipid metabolism. TNF-α, IL-6 and IL-1β are insulin antagonist and lipid metabolism is hampered by TNF-α. Elevated levels of CRP lead to insulin resistance. IF-α induces apoptosis of pancreatic β cells[70]. Non-enzymatic glycosylation of hemoglobin is not induced by inflammation, but rather results from hyperglycemia caused by insulin resistance[44]. Thus, this could explain why subjects with periodontitis have high HbA1c levels.

According to these reports, it can be presumed that control of periodontal inflammation after therapy may reduce the levels of local and circulatory mediators, such as IL-6 and TNF-α. Both may trigger acute phase proteins such as CRP, and impair intracellular insulin signaling. Consequently, if these mediators were reduced by periodontal treatment, this could theoretically, help in diabetes control. However, this mechanism remains to be confirmed. Some studies have shown that periodontal disease severity is correlated with blood CRP levels in diabetic patients[71,72], however CRP levels are not reduced after periodontal treatment[73,74].

CONCLUSION

Within the limits of this review we can conclude that: Periodontitis is a highly prevalent infectious disease that relates to some systemic disorders, including diabetes mellitus.

Diabetes has been associated to different oral diseases such as: xerostomia, neuro-sensory disorders, several oral mucosa diseases, tooth decay and periodontal disease. It is well documented in the literature that periodontal disease is more prevalent and severe in diabetic individuals than in healthy subjects. However, it has to be kept in mind that the level of metabolic control and duration of diabetes appear to influence the risk for periodontal disease, with a significant heterogeneity among diabetic individuals.

Periodontal treatment is effective in diabetic patients, but more long-term recurrence can be expected when diabetes is not well controlled.

Severe periodontitis is more frequently found in diabetic subjects with high HbA1c levels and systemic diabetic complications; however, the influence of periodontal treatment on HbA1c is not that well established. The beneficial effects of periodontal treatment on HbA1c levels seem to be more apparent in type 2 diabetics and when antibiotics are associated to local periodontal therapy, although other reports did not find any improvement in diabetes control after periodontal treatment. More research on type 1 and type 2 diabetic subjects will be needed to know how periodontal treatment affects diabetes metabolic control. In those, it will be paramount to control other factors that may affect HbA1c levels, such as diabetic medication, diet and physical exercise.

HbA1c reduction after periodontal treatment is usually less than 0.5%. New studies are needed to evaluate the clinical significance of this improvement.

Additionally, it may be necessary to explore the effects of different modalities of periodontal therapy in patients with different types of diabetes and different degrees of metabolic control.

Further analysis of inflammatory mediators, such as CRP, may help to explain the relationship between diabetes and periodontal disease, and the individual variations detected in samples from different severities of diabetes and periodontal disease.

Any improvement in the control of diabetes and/or periodontal disease has the potential to improve significantly the quality of life in diabetic subjects.